Fudan University
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1905-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.fudan.edu.cn
Exploratory Platform Research on Precision Therapy of Advanced Pancreatic Cancer
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-08-09
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 120
- Registration Number
- NCT06547736
- Locations
- 🇨🇳
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University, Shanghai, Shanghai, China
Secondary Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for PARP Inhibitors Resistance Patients
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-08-09
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 94
- Registration Number
- NCT06544460
- Locations
- 🇨🇳
Fudan university shanghai cancer center, Deparment of gynecologic oncology, Shanghai, Shanghai, China
A Prospective Cohort Study on the Serum Kisspeptin Levels Throughout Pregnancy in PCOS
- First Posted Date
- 2024-08-09
- Last Posted Date
- 2024-08-14
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 180
- Registration Number
- NCT06545994
- Locations
- 🇨🇳
OB & GYN Hospital of Fudan University, Shanghai, Shanghai, China
Primary Tumor Resection for M1a Stage Lung Cancer
Recruiting
- Conditions
- First Posted Date
- 2024-08-09
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 66
- Registration Number
- NCT06547710
- Locations
- 🇨🇳
Fudan University Cancer Center, Shanghai, Shanghai, China
Prehabilitation During Neoadjuvant Chemoradiotherapy for Rectal Cancer
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2024-08-07
- Last Posted Date
- 2024-08-07
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 108
- Registration Number
- NCT06542354
- Locations
- 🇨🇳
Zhongshan Hospital Fudan University, Shanghai, Shanghai, China
RET Inhibitor for Neoadjuvant Therapy in Locally Advanced RET-altered Thyroid Cancer
- First Posted Date
- 2024-07-31
- Last Posted Date
- 2024-08-02
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 48
- Registration Number
- NCT06530316
- Locations
- 🇨🇳
Fudan Univeristy Shanghai Cancer Center, Shanghai, China
RW Study of Adjuvant Radiotherapy in Locally Advanced Thyroid Cancer
- First Posted Date
- 2024-07-29
- Last Posted Date
- 2024-07-30
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 80
- Registration Number
- NCT06524167
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, China
Standard Systemic Therapy Combined With High/Low-dose Radiotherapy Plus Toripalimab for Metastatic Colorectal Cancer
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-07-29
- Last Posted Date
- 2024-07-29
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 96
- Registration Number
- NCT06525428
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
Foot Perfusion by Dynamic Contrast Enhanced MRI in Patients With Peripheral Artery Disease
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-07-29
- Last Posted Date
- 2024-07-29
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 30
- Registration Number
- NCT06525415
Toripalimab Combined With Targeted Therapy and Chemotherapy With or Without Radiotherapy as First-Line Treatment for Advanced Colorectal Cancer
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-07-26
- Last Posted Date
- 2024-07-26
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 208
- Registration Number
- NCT06521866
© Copyright 2024. All Rights Reserved by MedPath